Continuous intravenous adrenalin and noradrenalin infusion; effect of circulation and certain blood carbohydrates, lipids, and phosphorus fractions in normal persons and patients with neurocirculatory asthenia.
D001686:Biological Phenomena; D001769:Blood; D001775:Blood Circulation / Q000187:drug effects*; D001786:Blood Glucose / Q000187:drug effects*; D004837:Epinephrine / Q000494:pharmacology*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008945:Mitral Valve Prolapse; D009449:Neurocirculatory Asthenia / Q000097:blood*; D009638:Norepinephrine / Q000494:pharmacology*; D010758:Phosphorus / Q000097:blood*; D016226:Phosphorus, Dietary; D010829:Physiological Phenomena
D001786:Blood Glucose; D008055:Lipids; D016226:Phosphorus, Dietary; D010758:Phosphorus; D009638:Norepinephrine; D004837:Epinephrine
ARTERENOL/effects; BLOOD; BLOOD CIRCULATION/effect of drugs on; BLOOD SUGAR/effect of drugs on; EPINEPHRINE/effects; LIPIDS/in blood; NEUROCIRCULATORY ASTHENIA/blood in; PHOSPHORUS/in blood